COASTLANDS CAPITAL LP reported 1 transaction at ELOXX PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/30/2026ACC: 0001104659-26-068440
10% Owner
Since Apr 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.25M acquired · 1.25M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−1.25M
Price / share
—
Trade value
—
% of position
New position
5/27/2026
1.25M→0.00
Total
Net shares
−1.25M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/27/2026 | J · J | −1.25M | — | — | New position | 1.25M | 0.00 |
| Total | −1.25M | $0.00 | ||||||
Derivative Transactions1
Pre-funded Warrant
Indirect
Converts to
Common Stock
1.25M shares
Shares
+1.25M
Strike price
0.01
Held after
30.61M
Exercisable
—
5/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-funded Warrant Indirect | Common Stock1.25M shares | 5/27/2026 | J · J | +1.25M | 0.01 | — | 30.61M |